Rhelion Life Sciences Company Description
Rhelion Life Sciences Corp. engages in the production, growth, and sale of functional mushrooms and mushroom home grow kits to the recreational market in North America and Europe.
The company is also involved in the selection, distribution, and export of truffles, cannabidiol products, cannabis seeds, headshop products, growshop goods, cannabis bake house muffins, cookies, and cakes.
Its products also include PEX010, a natural psilocybin drug candidate for depression, PTSD, cancer-related distress and substance use disorders; IBEXX, a botanical ibogaine drug candidate for substance use disorders; and MB2500, a whole-leaf coca extract drug candidate for neuropsychiatric indications.
It sells its products under the iMicrodose, Maka, Happy Caps, and Mistercap’s brands through brick-and-mortar SmartShops, as well as through online stores.
The company was formerly known as Red Light Holland Corp. and changed its name to Rhelion Life Sciences Corp. in August 2026.
Rhelion Life Sciences Corp. is based in Toronto, Canada.
| Country | Canada |
| Industry | Security Brokers, Dealers, and Flotation Companies |
| CEO | Todd Shapiro |
Contact Details
Address: 1 Adelaide Street East Toronto, ON M5C 2V9 Canada | |
| Phone | 647 204 7129 |
| Website | rhelion.com |
Stock Details
| Ticker Symbol | RHEL |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | April - March |
| Reporting Currency | CAD |
| SIC Code | 6211 |
Key Executives
| Name | Position |
|---|---|
| Todd Shapiro | Chief Executive Officer |
| Keith Li | Chief Financial Officer |
| Lisa Ranken | Chief Operating Officer |